PROSTATE CANCER ADVISOR

Prostate Cancer

Features

Metastatic Prostate Cancer: Investigators Ponder New Path to Improve Survival

Greater effort should be directed at detecting and aggressively treating prostate cancer metastasis earlier, an approach made possible with the advent of highly sensitive and specific molecular imaging techniques and potent anticancer agents.
Now Is the Time: Reconsider PSA Screening Guidelines

Over the past decade, there has been a profound increase in diagnoses of metastatic prostate cancer.
Study: 177Lutetium-PSMA-617 After 223Radium for mCRPC Safe, Effective

Treatment with 177lutetium-PSMA-617 (177Lu-PSMA) is safe and effective in patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously received 223radium (223Ra), according to study findings presented at the European Society for Medical Oncology’s 2022 Congress (ESMO 2022) in Paris, France. In a study of 133 patients who participated in the RALU trial, Kambiz Rahbar,…
Prostate Cancer CTC PSMA Status Could Guide Therapy

PSMA expression on circulating tumor cells in men with mCRPC increases upon disease progression despite treatment with novel antiandrogens.
Survival Improving in Metastatic Castration-Sensitive Prostate Cancer Population

Increase in survival of men with mCSPC during 2015-2019 coincides with the use of docetaxel and novel hormonal therapies for this disease state.

Latest Prostate Cancer News

Comparing Medicare Drug Plans May Ease Prostate Cancer Financial Toxicity

By

Natasha Persaud

September 18, 2023

Less than 30% of patients report comparing drug costs before selecting a Medicare Part D plan.

Cigarette Smoking Prostate Cancer Relapse

Early-Onset Cancer Morbidity Continuing to Increase

September 18, 2023

Main risk factors underlying early-onset cancers are dietary risk factors, alcohol consumption, and tobacco use

Prostate Cancer Outcomes Worse With Higher Periprostatic vs Serum Testosterone

By

Natasha Persaud

September 15, 2023

Local testosterone delivery to the prostate bed might be a better marker of post-prostatectomy outcomes than serum testosterone in some men.

COVID-19 patient on a ventilator

Cancer Patients More Likely to Die From Early Omicron Variants of SARS-CoV-2

By

Andrea S. Blevins Primeau, PhD, MBA

September 15, 2023

Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.

PSA blood test

Prostate Cancer Biochemical Recurrence Risk Stratification Falls Short

By

Natasha Persaud

September 14, 2023

More stringent criteria are needed to define truly low-risk biochemical recurrence of prostate cancer following surgery and radiation treatment.

A cancer/chemo patient working out of her home with a phone and laptop

Administrative Tasks Required to Pay for Cancer Care May Prompt Nonadherence

By

Alexandra Della Pia, PharmD, MBA, BCOP

September 13, 2023

The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.

Bladder Cancer Adjuvant Chemotherapy Support

Intensified Neoadjuvant Therapy Improves Outcomes in Very High-Risk Prostate Cancer

By

Natasha Persaud

September 12, 2023

Investigators compared ADT plus abiraterone or docetaxel with ADT alone.

Doctor and patient wearing masks looking at laptop

Chatbot Responses to Top Cancer Questions Accurate but Have Limitations

September 12, 2023

Responses are moderately understandable, not readily actionable, and written at college reading level

Lorazepam Use Linked to Shorter PFS, OS in Several Cancers

By

Julie Ehlers

September 8, 2023

Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.

Generic Tablets in Close Up with Bottle

The Impact of Statins on Prevention of Certain Cancers

By

Ron Goldberg

September 6, 2023

Statin use does not have an effect on risk for lung, colorectal, prostate, and breast cancer.

Next post in Prostate Cancer

Cigarette Smoking Prostate Cancer Relapse

Early-Onset Cancer Morbidity Continuing to Increase